nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—ABCB1—melanoma	0.286	1	CbGaD
Bepridil—KCNQ1—ear—melanoma	0.0146	0.0984	CbGeAlD
Bepridil—CACNA1D—ear—melanoma	0.0101	0.0682	CbGeAlD
Bepridil—ATP1A1—optic choroid—melanoma	0.00914	0.0614	CbGeAlD
Bepridil—CALM2—ear—melanoma	0.00616	0.0414	CbGeAlD
Bepridil—CALM1—ear—melanoma	0.00613	0.0412	CbGeAlD
Bepridil—CACNA2D2—neck—melanoma	0.00536	0.036	CbGeAlD
Bepridil—KCNQ1—neck—melanoma	0.00518	0.0348	CbGeAlD
Bepridil—Electrocardiogram QT prolonged—Vemurafenib—melanoma	0.00482	0.0529	CcSEcCtD
Bepridil—ATP1A1—hair follicle—melanoma	0.00369	0.0248	CbGeAlD
Bepridil—CALM2—endothelium—melanoma	0.0033	0.0222	CbGeAlD
Bepridil—CALM1—endothelium—melanoma	0.00329	0.0221	CbGeAlD
Bepridil—CALM2—hair follicle—melanoma	0.00325	0.0218	CbGeAlD
Bepridil—CACNA1A—head—melanoma	0.00322	0.0216	CbGeAlD
Bepridil—KCNQ1—mammalian vulva—melanoma	0.00305	0.0205	CbGeAlD
Bepridil—CALM2—blood vessel—melanoma	0.00304	0.0205	CbGeAlD
Bepridil—CALM1—blood vessel—melanoma	0.00303	0.0204	CbGeAlD
Bepridil—PDE1B—head—melanoma	0.00281	0.0189	CbGeAlD
Bepridil—Sinus tachycardia—Docetaxel—melanoma	0.00261	0.0287	CcSEcCtD
Bepridil—ATP1A1—neck—melanoma	0.00247	0.0166	CbGeAlD
Bepridil—PDE1A—head—melanoma	0.00235	0.0158	CbGeAlD
Bepridil—Arthritis—Vemurafenib—melanoma	0.00231	0.0254	CcSEcCtD
Bepridil—CACNA2D2—head—melanoma	0.00226	0.0152	CbGeAlD
Bepridil—KCNQ1—head—melanoma	0.00219	0.0147	CbGeAlD
Bepridil—CALM2—neck—melanoma	0.00218	0.0146	CbGeAlD
Bepridil—CALM1—neck—melanoma	0.00217	0.0146	CbGeAlD
Bepridil—CALM3—eye—melanoma	0.00206	0.0139	CbGeAlD
Bepridil—CALM3—retina—melanoma	0.00204	0.0137	CbGeAlD
Bepridil—PDE1B—lymph node—melanoma	0.00196	0.0132	CbGeAlD
Bepridil—TNNC1—lymph node—melanoma	0.00188	0.0127	CbGeAlD
Bepridil—ATP1A1—eye—melanoma	0.00184	0.0124	CbGeAlD
Bepridil—ATP1A1—retina—melanoma	0.00182	0.0123	CbGeAlD
Bepridil—PDE1A—lymph node—melanoma	0.00165	0.0111	CbGeAlD
Bepridil—CALM3—mammalian vulva—melanoma	0.00164	0.011	CbGeAlD
Bepridil—CALM2—eye—melanoma	0.00162	0.0109	CbGeAlD
Bepridil—CALM1—eye—melanoma	0.00161	0.0108	CbGeAlD
Bepridil—CALM2—retina—melanoma	0.00161	0.0108	CbGeAlD
Bepridil—ATP1A1—skin of body—melanoma	0.0016	0.0108	CbGeAlD
Bepridil—CALM1—retina—melanoma	0.0016	0.0107	CbGeAlD
Bepridil—CACNA2D2—lymph node—melanoma	0.00158	0.0106	CbGeAlD
Bepridil—KCNQ1—lymph node—melanoma	0.00153	0.0103	CbGeAlD
Bepridil—CACNA1D—head—melanoma	0.00151	0.0102	CbGeAlD
Bepridil—ATP1A1—mammalian vulva—melanoma	0.00146	0.00981	CbGeAlD
Bepridil—Cardiac disorder—Vemurafenib—melanoma	0.00144	0.0158	CcSEcCtD
Bepridil—CALM2—skin of body—melanoma	0.00141	0.00947	CbGeAlD
Bepridil—CALM1—skin of body—melanoma	0.0014	0.00943	CbGeAlD
Bepridil—Arthritis—Bleomycin—melanoma	0.0014	0.0154	CcSEcCtD
Bepridil—CACNA1C—head—melanoma	0.0014	0.0094	CbGeAlD
Bepridil—CALM2—mammalian vulva—melanoma	0.00129	0.00864	CbGeAlD
Bepridil—CACNA1H—lymph node—melanoma	0.00129	0.00864	CbGeAlD
Bepridil—CALM1—mammalian vulva—melanoma	0.00128	0.0086	CbGeAlD
Bepridil—ABCB1—blood vessel—melanoma	0.00121	0.00813	CbGeAlD
Bepridil—Cough—Vemurafenib—melanoma	0.00118	0.013	CcSEcCtD
Bepridil—Liver function test abnormal—Dactinomycin—melanoma	0.00117	0.0129	CcSEcCtD
Bepridil—Myalgia—Vemurafenib—melanoma	0.00115	0.0126	CcSEcCtD
Bepridil—Liver function test abnormal—Carmustine—melanoma	0.0011	0.012	CcSEcCtD
Bepridil—CACNA1D—lymph node—melanoma	0.00106	0.00713	CbGeAlD
Bepridil—ATP1A1—head—melanoma	0.00104	0.00702	CbGeAlD
Bepridil—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00101	0.011	CcSEcCtD
Bepridil—CACNA1C—lymph node—melanoma	0.000979	0.00658	CbGeAlD
Bepridil—Decreased appetite—Vemurafenib—melanoma	0.00096	0.0105	CcSEcCtD
Bepridil—Gastrointestinal disorder—Vemurafenib—melanoma	0.000953	0.0105	CcSEcCtD
Bepridil—Constipation—Vemurafenib—melanoma	0.000944	0.0104	CcSEcCtD
Bepridil—CALM2—head—melanoma	0.00092	0.00618	CbGeAlD
Bepridil—CALM1—head—melanoma	0.000916	0.00615	CbGeAlD
Bepridil—Erectile dysfunction—Temozolomide—melanoma	0.000914	0.01	CcSEcCtD
Bepridil—Depression—Carmustine—melanoma	0.000913	0.01	CcSEcCtD
Bepridil—Depression—Temozolomide—melanoma	0.000882	0.00969	CcSEcCtD
Bepridil—Body temperature increased—Vemurafenib—melanoma	0.000873	0.00958	CcSEcCtD
Bepridil—Pharyngitis—Dactinomycin—melanoma	0.000872	0.00957	CcSEcCtD
Bepridil—KCNH2—head—melanoma	0.000833	0.0056	CbGeAlD
Bepridil—CALM3—lymph node—melanoma	0.00082	0.00551	CbGeAlD
Bepridil—Asthenia—Vemurafenib—melanoma	0.000792	0.0087	CcSEcCtD
Bepridil—Pharyngitis—Temozolomide—melanoma	0.000788	0.00865	CcSEcCtD
Bepridil—Cardiac failure—Docetaxel—melanoma	0.000782	0.00859	CcSEcCtD
Bepridil—Diarrhoea—Vemurafenib—melanoma	0.000755	0.00829	CcSEcCtD
Bepridil—Tinnitus—Temozolomide—melanoma	0.000741	0.00813	CcSEcCtD
Bepridil—Cardiac disorder—Temozolomide—melanoma	0.000737	0.00809	CcSEcCtD
Bepridil—Arrhythmia—Carmustine—melanoma	0.000734	0.00806	CcSEcCtD
Bepridil—ATP1A1—lymph node—melanoma	0.000731	0.00492	CbGeAlD
Bepridil—Dizziness—Vemurafenib—melanoma	0.00073	0.00802	CcSEcCtD
Bepridil—Cough—Bleomycin—melanoma	0.000715	0.00785	CcSEcCtD
Bepridil—Liver function test abnormal—Docetaxel—melanoma	0.000705	0.00774	CcSEcCtD
Bepridil—Myalgia—Bleomycin—melanoma	0.000698	0.00766	CcSEcCtD
Bepridil—Rash—Vemurafenib—melanoma	0.000696	0.00764	CcSEcCtD
Bepridil—Dermatitis—Vemurafenib—melanoma	0.000695	0.00764	CcSEcCtD
Bepridil—Headache—Vemurafenib—melanoma	0.000692	0.00759	CcSEcCtD
Bepridil—Vision blurred—Carmustine—melanoma	0.000674	0.0074	CcSEcCtD
Bepridil—Tremor—Carmustine—melanoma	0.00067	0.00736	CcSEcCtD
Bepridil—Oedema—Bleomycin—melanoma	0.000669	0.00734	CcSEcCtD
Bepridil—Nausea—Vemurafenib—melanoma	0.000656	0.0072	CcSEcCtD
Bepridil—Vision blurred—Temozolomide—melanoma	0.000652	0.00715	CcSEcCtD
Bepridil—Myalgia—Dactinomycin—melanoma	0.000651	0.00714	CcSEcCtD
Bepridil—Tremor—Temozolomide—melanoma	0.000648	0.00711	CcSEcCtD
Bepridil—CALM2—lymph node—melanoma	0.000644	0.00433	CbGeAlD
Bepridil—Angina pectoris—Docetaxel—melanoma	0.000643	0.00706	CcSEcCtD
Bepridil—CALM1—lymph node—melanoma	0.000641	0.00431	CbGeAlD
Bepridil—ABCB1—retina—melanoma	0.000638	0.00429	CbGeAlD
Bepridil—Anorexia—Bleomycin—melanoma	0.000638	0.007	CcSEcCtD
Bepridil—Oedema—Dactinomycin—melanoma	0.000624	0.00685	CcSEcCtD
Bepridil—Vertigo—Temozolomide—melanoma	0.000621	0.00682	CcSEcCtD
Bepridil—Hypertension—Carmustine—melanoma	0.000618	0.00678	CcSEcCtD
Bepridil—Palpitations—Temozolomide—melanoma	0.000611	0.00671	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Bleomycin—melanoma	0.000609	0.00669	CcSEcCtD
Bepridil—Myalgia—Carmustine—melanoma	0.000609	0.00669	CcSEcCtD
Bepridil—Anxiety—Carmustine—melanoma	0.000607	0.00666	CcSEcCtD
Bepridil—Cough—Temozolomide—melanoma	0.000603	0.00662	CcSEcCtD
Bepridil—Paraesthesia—Bleomycin—melanoma	0.000601	0.00659	CcSEcCtD
Bepridil—Hypertension—Temozolomide—melanoma	0.000597	0.00655	CcSEcCtD
Bepridil—Dyspnoea—Bleomycin—melanoma	0.000596	0.00655	CcSEcCtD
Bepridil—Anorexia—Dactinomycin—melanoma	0.000595	0.00653	CcSEcCtD
Bepridil—Myalgia—Temozolomide—melanoma	0.000589	0.00646	CcSEcCtD
Bepridil—Anxiety—Temozolomide—melanoma	0.000587	0.00644	CcSEcCtD
Bepridil—Oedema—Carmustine—melanoma	0.000584	0.00641	CcSEcCtD
Bepridil—KCNH2—lymph node—melanoma	0.000583	0.00392	CbGeAlD
Bepridil—Decreased appetite—Bleomycin—melanoma	0.000581	0.00638	CcSEcCtD
Bepridil—Dry mouth—Temozolomide—melanoma	0.000576	0.00632	CcSEcCtD
Bepridil—Pain—Bleomycin—melanoma	0.000572	0.00628	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000568	0.00624	CcSEcCtD
Bepridil—Oedema—Temozolomide—melanoma	0.000564	0.00619	CcSEcCtD
Bepridil—Anorexia—Carmustine—melanoma	0.000557	0.00611	CcSEcCtD
Bepridil—Hyperhidrosis—Temozolomide—melanoma	0.000545	0.00599	CcSEcCtD
Bepridil—Decreased appetite—Dactinomycin—melanoma	0.000542	0.00595	CcSEcCtD
Bepridil—Anorexia—Temozolomide—melanoma	0.000538	0.00591	CcSEcCtD
Bepridil—Pain—Dactinomycin—melanoma	0.000533	0.00586	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Carmustine—melanoma	0.000532	0.00584	CcSEcCtD
Bepridil—Rhinitis—Docetaxel—melanoma	0.00053	0.00581	CcSEcCtD
Bepridil—Body temperature increased—Bleomycin—melanoma	0.000529	0.00581	CcSEcCtD
Bepridil—Insomnia—Carmustine—melanoma	0.000528	0.0058	CcSEcCtD
Bepridil—Paraesthesia—Carmustine—melanoma	0.000524	0.00576	CcSEcCtD
Bepridil—Pharyngitis—Docetaxel—melanoma	0.000524	0.00576	CcSEcCtD
Bepridil—Dyspnoea—Carmustine—melanoma	0.000521	0.00572	CcSEcCtD
Bepridil—Somnolence—Carmustine—melanoma	0.000519	0.0057	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Temozolomide—melanoma	0.000514	0.00564	CcSEcCtD
Bepridil—ABCB1—mammalian vulva—melanoma	0.000511	0.00343	CbGeAlD
Bepridil—Insomnia—Temozolomide—melanoma	0.00051	0.0056	CcSEcCtD
Bepridil—Gastrointestinal pain—Dactinomycin—melanoma	0.00051	0.0056	CcSEcCtD
Bepridil—CYP2D6—head—melanoma	0.000508	0.00341	CbGeAlD
Bepridil—Decreased appetite—Carmustine—melanoma	0.000508	0.00557	CcSEcCtD
Bepridil—Paraesthesia—Temozolomide—melanoma	0.000507	0.00556	CcSEcCtD
Bepridil—Gastrointestinal disorder—Carmustine—melanoma	0.000504	0.00553	CcSEcCtD
Bepridil—Dyspnoea—Temozolomide—melanoma	0.000503	0.00552	CcSEcCtD
Bepridil—Somnolence—Temozolomide—melanoma	0.000502	0.00551	CcSEcCtD
Bepridil—Constipation—Carmustine—melanoma	0.000499	0.00548	CcSEcCtD
Bepridil—Pain—Carmustine—melanoma	0.000499	0.00548	CcSEcCtD
Bepridil—Dyspepsia—Temozolomide—melanoma	0.000497	0.00545	CcSEcCtD
Bepridil—Abdominal pain—Dactinomycin—melanoma	0.000493	0.00541	CcSEcCtD
Bepridil—Body temperature increased—Dactinomycin—melanoma	0.000493	0.00541	CcSEcCtD
Bepridil—Decreased appetite—Temozolomide—melanoma	0.000491	0.00539	CcSEcCtD
Bepridil—Cardiac disorder—Docetaxel—melanoma	0.00049	0.00538	CcSEcCtD
Bepridil—Gastrointestinal disorder—Temozolomide—melanoma	0.000487	0.00535	CcSEcCtD
Bepridil—Constipation—Temozolomide—melanoma	0.000483	0.0053	CcSEcCtD
Bepridil—Pain—Temozolomide—melanoma	0.000483	0.0053	CcSEcCtD
Bepridil—Asthenia—Bleomycin—melanoma	0.00048	0.00527	CcSEcCtD
Bepridil—Gastrointestinal pain—Carmustine—melanoma	0.000477	0.00524	CcSEcCtD
Bepridil—Arrhythmia—Docetaxel—melanoma	0.000472	0.00518	CcSEcCtD
Bepridil—Abdominal pain—Carmustine—melanoma	0.000462	0.00507	CcSEcCtD
Bepridil—Body temperature increased—Carmustine—melanoma	0.000462	0.00507	CcSEcCtD
Bepridil—Gastrointestinal pain—Temozolomide—melanoma	0.000461	0.00507	CcSEcCtD
Bepridil—Asthenia—Dactinomycin—melanoma	0.000448	0.00491	CcSEcCtD
Bepridil—Abdominal pain—Temozolomide—melanoma	0.000446	0.0049	CcSEcCtD
Bepridil—Body temperature increased—Temozolomide—melanoma	0.000446	0.0049	CcSEcCtD
Bepridil—Diarrhoea—Dactinomycin—melanoma	0.000427	0.00469	CcSEcCtD
Bepridil—Rash—Bleomycin—melanoma	0.000422	0.00463	CcSEcCtD
Bepridil—Dermatitis—Bleomycin—melanoma	0.000421	0.00463	CcSEcCtD
Bepridil—Asthenia—Carmustine—melanoma	0.000419	0.0046	CcSEcCtD
Bepridil—Syncope—Docetaxel—melanoma	0.000412	0.00453	CcSEcCtD
Bepridil—Palpitations—Docetaxel—melanoma	0.000406	0.00446	CcSEcCtD
Bepridil—Asthenia—Temozolomide—melanoma	0.000405	0.00444	CcSEcCtD
Bepridil—Loss of consciousness—Docetaxel—melanoma	0.000404	0.00444	CcSEcCtD
Bepridil—Cough—Docetaxel—melanoma	0.000401	0.0044	CcSEcCtD
Bepridil—Diarrhoea—Carmustine—melanoma	0.0004	0.00439	CcSEcCtD
Bepridil—Nausea—Bleomycin—melanoma	0.000397	0.00436	CcSEcCtD
Bepridil—Hypertension—Docetaxel—melanoma	0.000397	0.00436	CcSEcCtD
Bepridil—Rash—Dactinomycin—melanoma	0.000393	0.00432	CcSEcCtD
Bepridil—Myalgia—Docetaxel—melanoma	0.000391	0.0043	CcSEcCtD
Bepridil—Dizziness—Carmustine—melanoma	0.000386	0.00424	CcSEcCtD
Bepridil—Diarrhoea—Temozolomide—melanoma	0.000386	0.00424	CcSEcCtD
Bepridil—Dry mouth—Docetaxel—melanoma	0.000383	0.0042	CcSEcCtD
Bepridil—Oedema—Docetaxel—melanoma	0.000375	0.00412	CcSEcCtD
Bepridil—Dizziness—Temozolomide—melanoma	0.000373	0.0041	CcSEcCtD
Bepridil—Nausea—Dactinomycin—melanoma	0.000371	0.00407	CcSEcCtD
Bepridil—Shock—Docetaxel—melanoma	0.000369	0.00405	CcSEcCtD
Bepridil—Rash—Carmustine—melanoma	0.000368	0.00404	CcSEcCtD
Bepridil—Dermatitis—Carmustine—melanoma	0.000368	0.00404	CcSEcCtD
Bepridil—Headache—Carmustine—melanoma	0.000366	0.00402	CcSEcCtD
Bepridil—ABCB1—head—melanoma	0.000366	0.00246	CbGeAlD
Bepridil—Anorexia—Docetaxel—melanoma	0.000358	0.00393	CcSEcCtD
Bepridil—Rash—Temozolomide—melanoma	0.000356	0.00391	CcSEcCtD
Bepridil—Dermatitis—Temozolomide—melanoma	0.000355	0.0039	CcSEcCtD
Bepridil—Headache—Temozolomide—melanoma	0.000353	0.00388	CcSEcCtD
Bepridil—Nausea—Carmustine—melanoma	0.000347	0.00381	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Docetaxel—melanoma	0.000342	0.00375	CcSEcCtD
Bepridil—Insomnia—Docetaxel—melanoma	0.000339	0.00373	CcSEcCtD
Bepridil—Paraesthesia—Docetaxel—melanoma	0.000337	0.0037	CcSEcCtD
Bepridil—Nausea—Temozolomide—melanoma	0.000335	0.00368	CcSEcCtD
Bepridil—Dyspnoea—Docetaxel—melanoma	0.000335	0.00367	CcSEcCtD
Bepridil—Somnolence—Docetaxel—melanoma	0.000334	0.00366	CcSEcCtD
Bepridil—Dyspepsia—Docetaxel—melanoma	0.00033	0.00363	CcSEcCtD
Bepridil—Decreased appetite—Docetaxel—melanoma	0.000326	0.00358	CcSEcCtD
Bepridil—Gastrointestinal disorder—Docetaxel—melanoma	0.000324	0.00356	CcSEcCtD
Bepridil—Constipation—Docetaxel—melanoma	0.000321	0.00352	CcSEcCtD
Bepridil—Pain—Docetaxel—melanoma	0.000321	0.00352	CcSEcCtD
Bepridil—Gastrointestinal pain—Docetaxel—melanoma	0.000307	0.00337	CcSEcCtD
Bepridil—Abdominal pain—Docetaxel—melanoma	0.000297	0.00326	CcSEcCtD
Bepridil—Body temperature increased—Docetaxel—melanoma	0.000297	0.00326	CcSEcCtD
Bepridil—Asthenia—Docetaxel—melanoma	0.000269	0.00296	CcSEcCtD
Bepridil—Diarrhoea—Docetaxel—melanoma	0.000257	0.00282	CcSEcCtD
Bepridil—ABCB1—lymph node—melanoma	0.000256	0.00172	CbGeAlD
Bepridil—Dizziness—Docetaxel—melanoma	0.000248	0.00272	CcSEcCtD
Bepridil—Rash—Docetaxel—melanoma	0.000237	0.0026	CcSEcCtD
Bepridil—Dermatitis—Docetaxel—melanoma	0.000236	0.0026	CcSEcCtD
Bepridil—Headache—Docetaxel—melanoma	0.000235	0.00258	CcSEcCtD
Bepridil—Nausea—Docetaxel—melanoma	0.000223	0.00245	CcSEcCtD
Bepridil—CALM2—Disease—CDKN1B—melanoma	5.94e-06	1.25e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CDKN1A—melanoma	5.94e-06	1.25e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CDKN1A—melanoma	5.94e-06	1.25e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—PTEN—melanoma	5.92e-06	1.25e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—PTEN—melanoma	5.92e-06	1.25e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NOTCH1—melanoma	5.91e-06	1.25e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NOTCH1—melanoma	5.91e-06	1.25e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGF—melanoma	5.91e-06	1.25e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—NFKB1—melanoma	5.89e-06	1.24e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—NFKB1—melanoma	5.89e-06	1.24e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—AKT1—melanoma	5.86e-06	1.24e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—AKT1—melanoma	5.86e-06	1.24e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—AKT1—melanoma	5.82e-06	1.23e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—CTNNB1—melanoma	5.8e-06	1.22e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CD80—melanoma	5.79e-06	1.22e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CD80—melanoma	5.79e-06	1.22e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CG—melanoma	5.78e-06	1.22e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APC—melanoma	5.78e-06	1.22e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APC—melanoma	5.78e-06	1.22e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KIT—melanoma	5.78e-06	1.22e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KIT—melanoma	5.78e-06	1.22e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CG—melanoma	5.78e-06	1.22e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—NRAS—melanoma	5.78e-06	1.22e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—NRAS—melanoma	5.78e-06	1.22e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AKT1—melanoma	5.75e-06	1.21e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—MAPK3—melanoma	5.73e-06	1.21e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGF—melanoma	5.72e-06	1.21e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGF—melanoma	5.72e-06	1.21e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—CDKN1A—melanoma	5.67e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PTEN—melanoma	5.65e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—AKT1—melanoma	5.63e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—AKT1—melanoma	5.63e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—BRAF—melanoma	5.62e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—CTNNB1—melanoma	5.61e-06	1.18e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—CTNNB1—melanoma	5.61e-06	1.18e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—MAPK3—melanoma	5.54e-06	1.17e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—MAPK3—melanoma	5.54e-06	1.17e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—CDKN1A—melanoma	5.48e-06	1.16e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—CDKN1A—melanoma	5.48e-06	1.16e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CB—melanoma	5.48e-06	1.16e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—STAT3—melanoma	5.48e-06	1.15e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF1—melanoma	5.47e-06	1.15e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PTEN—melanoma	5.47e-06	1.15e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PTEN—melanoma	5.47e-06	1.15e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—NRAS—melanoma	5.46e-06	1.15e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—MAPK1—melanoma	5.45e-06	1.15e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—melanoma	5.45e-06	1.15e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—BRAF—melanoma	5.44e-06	1.15e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—BRAF—melanoma	5.44e-06	1.15e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—melanoma	5.43e-06	1.14e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CG—melanoma	5.42e-06	1.14e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CB—melanoma	5.3e-06	1.12e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CB—melanoma	5.3e-06	1.12e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—STAT3—melanoma	5.3e-06	1.12e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—STAT3—melanoma	5.3e-06	1.12e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF1—melanoma	5.3e-06	1.12e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF1—melanoma	5.3e-06	1.12e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAP2K1—melanoma	5.29e-06	1.12e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—NRAS—melanoma	5.28e-06	1.11e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—NRAS—melanoma	5.28e-06	1.11e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—MAPK1—melanoma	5.27e-06	1.11e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—MAPK1—melanoma	5.27e-06	1.11e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—melanoma	5.27e-06	1.11e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—melanoma	5.27e-06	1.11e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CD—melanoma	5.26e-06	1.11e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—melanoma	5.25e-06	1.11e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—melanoma	5.25e-06	1.11e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK3—melanoma	5.23e-06	1.1e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PPARG—melanoma	5.23e-06	1.1e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—KRAS—melanoma	5.15e-06	1.09e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAP2K1—melanoma	5.12e-06	1.08e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAP2K1—melanoma	5.12e-06	1.08e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CG—melanoma	5.11e-06	1.08e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CD—melanoma	5.08e-06	1.07e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CD—melanoma	5.08e-06	1.07e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK3—melanoma	5.06e-06	1.07e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK3—melanoma	5.06e-06	1.07e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—STAT3—melanoma	5.06e-06	1.07e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NRAS—melanoma	5.04e-06	1.06e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—FGF2—melanoma	5.03e-06	1.06e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK1—melanoma	4.98e-06	1.05e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—KRAS—melanoma	4.98e-06	1.05e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—KRAS—melanoma	4.98e-06	1.05e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—melanoma	4.98e-06	1.05e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARG—melanoma	4.93e-06	1.04e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—STAT3—melanoma	4.89e-06	1.03e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—STAT3—melanoma	4.89e-06	1.03e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NRAS—melanoma	4.88e-06	1.03e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NRAS—melanoma	4.88e-06	1.03e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FGF2—melanoma	4.87e-06	1.03e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FGF2—melanoma	4.87e-06	1.03e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MAPK3—melanoma	4.83e-06	1.02e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK1—melanoma	4.82e-06	1.02e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK1—melanoma	4.82e-06	1.02e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—melanoma	4.81e-06	1.02e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—melanoma	4.81e-06	1.02e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CD—melanoma	4.76e-06	1e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTEN—melanoma	4.73e-06	9.98e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—PIK3CA—melanoma	4.73e-06	9.97e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MDM2—melanoma	4.71e-06	9.93e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ALB—melanoma	4.7e-06	9.92e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—KRAS—melanoma	4.7e-06	9.92e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—MYC—melanoma	4.7e-06	9.91e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—MAPK3—melanoma	4.67e-06	9.85e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—MAPK3—melanoma	4.67e-06	9.85e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ERBB2—melanoma	4.64e-06	9.79e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—MAPK1—melanoma	4.6e-06	9.69e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—melanoma	4.59e-06	9.69e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CB—melanoma	4.58e-06	9.66e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTEN—melanoma	4.58e-06	9.66e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTEN—melanoma	4.58e-06	9.66e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—PIK3CA—melanoma	4.57e-06	9.64e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—PIK3CA—melanoma	4.57e-06	9.64e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MDM2—melanoma	4.55e-06	9.61e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MDM2—melanoma	4.55e-06	9.61e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—KRAS—melanoma	4.55e-06	9.59e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—KRAS—melanoma	4.55e-06	9.59e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—MYC—melanoma	4.54e-06	9.58e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—MYC—melanoma	4.54e-06	9.58e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ERBB2—melanoma	4.49e-06	9.47e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ERBB2—melanoma	4.49e-06	9.47e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CD—melanoma	4.49e-06	9.47e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—MAPK1—melanoma	4.45e-06	9.38e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—MAPK1—melanoma	4.45e-06	9.38e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—melanoma	4.44e-06	9.37e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—melanoma	4.44e-06	9.37e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CB—melanoma	4.43e-06	9.35e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CB—melanoma	4.43e-06	9.35e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ALB—melanoma	4.43e-06	9.35e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCL8—melanoma	4.4e-06	9.28e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HRAS—melanoma	4.37e-06	9.22e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—KRAS—melanoma	4.34e-06	9.15e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—PIK3CA—melanoma	4.32e-06	9.11e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CDKN1B—melanoma	4.3e-06	9.07e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCL8—melanoma	4.26e-06	8.98e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCL8—melanoma	4.26e-06	8.98e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HRAS—melanoma	4.23e-06	8.92e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HRAS—melanoma	4.23e-06	8.92e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CASP3—melanoma	4.21e-06	8.89e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL2—melanoma	4.21e-06	8.87e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—KRAS—melanoma	4.2e-06	8.86e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—KRAS—melanoma	4.2e-06	8.86e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—melanoma	4.19e-06	8.83e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—PIK3CA—melanoma	4.18e-06	8.81e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—PIK3CA—melanoma	4.18e-06	8.81e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CDKN1B—melanoma	4.16e-06	8.77e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CDKN1B—melanoma	4.16e-06	8.77e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CB—melanoma	4.15e-06	8.76e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—melanoma	4.11e-06	8.68e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCND1—melanoma	4.1e-06	8.65e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CASP3—melanoma	4.08e-06	8.6e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CASP3—melanoma	4.08e-06	8.6e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL2—melanoma	4.07e-06	8.58e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL2—melanoma	4.07e-06	8.58e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CTNNB1—melanoma	4.06e-06	8.57e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—melanoma	4.05e-06	8.54e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—melanoma	4.05e-06	8.54e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—HRAS—melanoma	4e-06	8.43e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—PIK3CA—melanoma	3.99e-06	8.41e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MMP9—melanoma	3.98e-06	8.4e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CDKN1A—melanoma	3.97e-06	8.37e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCND1—melanoma	3.97e-06	8.37e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCND1—melanoma	3.97e-06	8.37e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PTEN—melanoma	3.96e-06	8.35e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NFKB1—melanoma	3.94e-06	8.31e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CTNNB1—melanoma	3.93e-06	8.29e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CTNNB1—melanoma	3.93e-06	8.29e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CB—melanoma	3.91e-06	8.25e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—melanoma	3.88e-06	8.18e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—HRAS—melanoma	3.87e-06	8.15e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—HRAS—melanoma	3.87e-06	8.15e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AKT1—melanoma	3.86e-06	8.14e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—PIK3CA—melanoma	3.86e-06	8.14e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—PIK3CA—melanoma	3.86e-06	8.14e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MMP9—melanoma	3.85e-06	8.12e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MMP9—melanoma	3.85e-06	8.12e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CDKN1A—melanoma	3.84e-06	8.09e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CDKN1A—melanoma	3.84e-06	8.09e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PTEN—melanoma	3.83e-06	8.08e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PTEN—melanoma	3.83e-06	8.08e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—melanoma	3.82e-06	8.07e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NFKB1—melanoma	3.81e-06	8.04e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NFKB1—melanoma	3.81e-06	8.04e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AKT1—melanoma	3.74e-06	7.88e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AKT1—melanoma	3.74e-06	7.88e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—melanoma	3.7e-06	7.8e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—melanoma	3.7e-06	7.8e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—HRAS—melanoma	3.69e-06	7.78e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTEN—melanoma	3.59e-06	7.57e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—melanoma	3.58e-06	7.54e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—HRAS—melanoma	3.57e-06	7.53e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—HRAS—melanoma	3.57e-06	7.53e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—STAT3—melanoma	3.54e-06	7.47e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NRAS—melanoma	3.53e-06	7.45e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—melanoma	3.53e-06	7.45e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—AKT1—melanoma	3.53e-06	7.44e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—melanoma	3.46e-06	7.29e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—melanoma	3.46e-06	7.29e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—STAT3—melanoma	3.42e-06	7.22e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—STAT3—melanoma	3.42e-06	7.22e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NRAS—melanoma	3.42e-06	7.21e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NRAS—melanoma	3.42e-06	7.21e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—melanoma	3.42e-06	7.2e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—melanoma	3.42e-06	7.2e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—AKT1—melanoma	3.41e-06	7.2e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—AKT1—melanoma	3.41e-06	7.2e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK3—melanoma	3.38e-06	7.13e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTEN—melanoma	3.38e-06	7.13e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CA—melanoma	3.34e-06	7.04e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MYC—melanoma	3.29e-06	6.94e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK3—melanoma	3.27e-06	6.9e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK3—melanoma	3.27e-06	6.9e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—AKT1—melanoma	3.26e-06	6.87e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CA—melanoma	3.23e-06	6.81e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CA—melanoma	3.23e-06	6.81e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK1—melanoma	3.22e-06	6.79e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—melanoma	3.22e-06	6.79e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MYC—melanoma	3.18e-06	6.71e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MYC—melanoma	3.18e-06	6.71e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—AKT1—melanoma	3.15e-06	6.65e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—AKT1—melanoma	3.15e-06	6.65e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK1—melanoma	3.11e-06	6.57e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK1—melanoma	3.11e-06	6.57e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—melanoma	3.11e-06	6.56e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—melanoma	3.11e-06	6.56e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KRAS—melanoma	3.04e-06	6.41e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KRAS—melanoma	2.94e-06	6.2e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KRAS—melanoma	2.94e-06	6.2e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CA—melanoma	2.79e-06	5.89e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AKT1—melanoma	2.73e-06	5.75e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—melanoma	2.7e-06	5.7e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CA—melanoma	2.7e-06	5.7e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CA—melanoma	2.7e-06	5.7e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AKT1—melanoma	2.64e-06	5.57e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AKT1—melanoma	2.64e-06	5.57e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—melanoma	2.61e-06	5.51e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—melanoma	2.61e-06	5.51e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HRAS—melanoma	2.58e-06	5.45e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CA—melanoma	2.53e-06	5.34e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HRAS—melanoma	2.5e-06	5.27e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HRAS—melanoma	2.5e-06	5.27e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—melanoma	2.47e-06	5.22e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—melanoma	2.39e-06	5.05e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—melanoma	2.39e-06	5.05e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CA—melanoma	2.39e-06	5.03e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT1—melanoma	2.28e-06	4.81e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT1—melanoma	2.21e-06	4.65e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT1—melanoma	2.21e-06	4.65e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AKT1—melanoma	2.07e-06	4.36e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AKT1—melanoma	1.95e-06	4.11e-06	CbGpPWpGaD
